Grupo Casa Saba, S.A. (ADR) (NYSE:SAB)
The Company, through its subsidiaries, distributes pharmaceutical products, as well as health-and-beauty/other products, entertainment products, food/non-perishable products and office/electronic products.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
This company is trading below tangible assets and has a strong financial position with little debt. Generic pharma should be a strong industry in tough economic times and this company has little competition in an emerging market, causing it's profitability to be double the industry standard. This stock is probably undervalued because it lacks coverage from Wall St.
Recs
Recs
The company is trading at net tangible assets, is profitable, debt-free, and growing revenue. The Enterprise value to revenue ratio for SAB is very low at 0.21.
Recs
Wholesale drugs - great intrinsic value to price ratio
Recs
Stock started out underperforming but was able to rebound and outperform the S&P trend.
Recs
Massively undervalued.
Recs
Committed owner, coampany been around since 1900, and in good supply chain with good business in growing market.
Recs
good stock rising
Recs
- Return on Equity = 16.9%
- Currently trading at 1.2x FCF!!!!
- PEG = 1.7
- Price-to-Book = 1.8
- Extremely low debt (debt to income = 2%)
- With 7% growth and a current yearly EPS of $3.46 I calculate this stocks value at $75
Mexico is an emerging market poised to benefit from immigration reform in the U.S. SABA will capitalize on the growth and and advancement of Mexico.
Recs
lot of cash more that its equity almost monopolic wholesale of drugs in mexico,low debt
Recs
Recs
5 Star/Small cap/Pays dividend
Recs
Are you kidding me? BUY
Recs
Great under the radar stock with excellant fundatmentals.... Should be worth twice the current levels, one instuitional holder owns 85% of all outstanding shares. See my full analysis at:
http://etstockideas.blogspot.com/2006/10/sab-grupo-casa-saba-sa-de-cv.html
Recs
P/E is less than half that of industry average, P/cash flow is 48% of S&P, P/sales is 0.3. It has no debt, high insider ownership, and a >2% div yield. No special insight - just nice value numbers.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 15 of 15